Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Cavotec SA in connection with rights issue
Mandate

Vinge has advised Cavotec SA in connection with rights issue

January 15, 2019 Capital Markets and Public M&A

Cavotec SA (Nasdaq Stockholm) has completed a rights issue of shares, whereby Cavotec SA raised proceeds of MSEK 204, before issue costs.

Cavotec is a leading engineering group that designs and manufactures automated connection and electrification systems for ports, airports and industrial applications worldwide. 

Vinge has advised Cavotec in relation to Swedish law. Vinge’s team has mainly consisted of Jesper Schönbeck, Malte Hedlund, Edin Agic and Anna-Karin Alin. Maria Schultzberg and Henrik Wastenson advised on tax issues.
 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026